阿斯利康全球肿瘤业务 Dato-DXd 及肺癌事业部负责人赖明隆已决定离职

Zhitong
2025.06.15 11:45

According to reporters, Lai Minglong, head of AstraZeneca's global oncology business Dato-DXd and lung cancer division, has decided to leave the company to seek external development opportunities, with his last working day being June 30. AstraZeneca confirmed to reporters that the news is true. Public information shows that Lai Minglong joined AstraZeneca in June 2017 as Vice President of AstraZeneca China's Cardiovascular and Metabolism Business Unit and was promoted to General Manager of AstraZeneca China in 2018

来源：Zhitong 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。